Concurrent Chemoradiation for Unresectable Pancreatic Cancer
![]() |
Kim, Yong-Bae
(Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine)
Seong, Jin-Sil (Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine) Song, Si-Young (Department of Internal Medicine, Brain Korea 21 Project for Medical Science, Yonsei Cancer Center, Yonsei University College of Medicine) Park, Seung-Woo (Department of Internal Medicine, Brain Korea 21 Project for Medical Science, Yonsei Cancer Center, Yonsei University College of Medicine) Suh, Chang-Ok (Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine) |
1 | McGinn CJ, ZaIupski MM, Shureiqi I, et aI. Phase I Trial of radiation dose escalation with concurrent weekly full-dose gemcitabine in patients with advanced pancreatic cancer. J CIin Oncol 2001;19:4102-4208 |
2 | Hoffman JP, McGinn CJ, Ross E, et aI. A Phase I Trial of preoperative gemcitabine for patients with locaIized,resectabIe pancreatic adenocarcinoma. Cancer Invest 1999;17:30-32 DOI ScienceOn |
3 | Whang YW, Chang HJ, Lee JK, et aI. Survival and recurrence pattern after cfter curative resection of pancreatic cancer. Korean J Gastroenterol 2001;38:276-283 |
4 | MiIas L, Fujii T, Hunter NR, et aI. Enhancement of tumor radioresponse in vivo by gemcitabine. Cancer Res 1999;59:107-114 |
5 | Kudrimoti M, Regine W, John W, et aI. Concurrent infusional gemcitabine and radiation in the treatment of advanced unresectabIe GI maIignancy : A phase I/II study. Proc Am Soc Clin Oncol 1999;28:242a |
6 | Merrick III HW, DobeIbower RR. Aggressive therapy for cancer of the pancreas-dose it help? Gastroenterol CIin North Am 1990;19:935-962 |
7 | Lee SJ, Lee YC, Song SY, et aI. Clinical study on pancreatic cancer and its prognostic factors. Korean J Gastroenterol 1994;26:1010-1020 |
8 | EpeIbaum R, RosenbIatt E, NasraIIah S, et aI. Phase II study of gemcitabine pancreatic cancer. Eur J Cancer 1999;35:S148-149 |
9 | MoerteI CG, ChiIds DS, Reitemeier RJ, CoIby MY, HoIbrook MA. Combined 5-fluorouraciI and supervoltage radiation therapy of locally unresectabIe gasrointestinal cancer. Lancet 1969;2:865-867 |
10 | The GastrointestinaI Tumor Study Group. Treatment of locally unresectable carcinoma of the pancreas : Comparison of combined-modaIity therapy (chemotherapy plus radiotherapy) to chemotherapy alone. J Natl Cancer Inst 1988;80:751-755 DOI |
11 | Lawrence TS, Eisbruch A, Shewach DS. Gemcitabinemediated radiosensitization. Semin Oncol 1997;24(2, S7):24-28 |
12 | Safran H, Moore T, Iannitti D, et aI. Paclitaxel and concurrent radiation for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 2001;49:1275-1279 DOI PUBMED ScienceOn |
13 | Rowinsky EK, WindIe JJ, Von Hoff DD. Ras protein farnesyltransferase : a strategic target for anticancer therapeutic development. J CIin Oncol 1999;17:3631 |
14 | Huang NJ, HitteIman WN. Transient inhibition of chromosome damage repair after after ionizing radiation by gemcitabine. Proc Am Assoc Cancer Res 1995;36:612 |
15 | Lawrence TS, Chang EY, HerteI L, et aI. Gemcitabine radiosensitizes human pancreatic cancer cells. Proc Am Assoc Cancer Res 1994;35:647 |
16 | Mason KA, MiIas L, Hunter NR, et aI. Maximizing therapeutic gain with gemcitabine and fractionated radiation. Int J Radiat Oncol Biol Phys 1999;44:1125-1135 DOI PUBMED ScienceOn |
17 | BIackstock AW, Bernard SA, Richards F, et aI. Phase I trial of twice-weekly gemcitabine and concurrent radiation in patients with advanced pancreatic cancer. J Clin Oncol 1999;17:2208-2212 |
18 | Abad A, AreIIano A, Brunet J, et aI. Gemcitabine plus radiotherapy in stage II-III pancreatic cancer : A phase I trial. Ann Oncol 1998;9:53 |
19 | CentraI Cancer Registry Center, Ministry of HeaIth and WeIfare, Korea. Annnal report of the central cancer registry in Korea. 2000 |
20 | Safran H, King TP, Choy H, et aI. Paclitaxel and concurrent radiation for Iocally advanced pancreatic and gastric cancer : a phase I study. J CIin Oncol 1997;15:901-907 |
21 | Wong S, Oza AM, BrierIey J, et aI. Phase I study of gemcitabine and escaIating dose radiation therapy in patients with pancreatic carcinoma. Proc Am Soc CIin Oncol 2000;19:268a |
22 | Hak C, Rodriguez FF, Koester S, HiIsenbeck S, Von Hoff D. Investigation of Taxol as a potential radiation sensitizer. Cancer 1993;71:3774-8 DOI ScienceOn |
23 | WoIff R, Janjan N, Lenzi R, et aI. Treatment related toxicities with rapid-fractionation external beam radiation and concomitant gemcitabine for Iocally advanced nonmetastatic adenocarcinoma of the pancreas. Int J Radiat Oncol Biol Phys 1998;42:201 |
24 | MoerteI CG, Frytak S, Hahn RG, et aI. Therapy of Iocally unreaectabIe pancreatic carcinoma : A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads+5-fluorouracil), and high dose radiation+5-fluorouracil : The Gastrointestinal Tumor Study Group. Cancer 1981;48:1705-1710 |
![]() |